Loading…

Longitudinally monitored immune biomarkers predict the timing of COVID-19 outcomes

The clinical outcome of SARS-CoV-2 infection varies widely between individuals. Machine learning models can support decision making in healthcare by assessing fatality risk in patients that do not yet show severe signs of COVID-19. Most predictive models rely on static demographic features and clini...

Full description

Saved in:
Bibliographic Details
Published in:PLoS computational biology 2022-01, Vol.18 (1), p.e1009778
Main Authors: Lasso, Gorka, Khan, Saad, Allen, Stephanie A, Mariano, Margarette, Florez, Catalina, Orner, Erika P, Quiroz, Jose A, Quevedo, Gregory, Massimi, Aldo, Hegde, Aditi, Wirchnianski, Ariel S, Bortz, 3rd, Robert H, Malonis, Ryan J, Georgiev, George I, Tong, Karen, Herrera, Natalia G, Morano, Nicholas C, Garforth, Scott J, Malaviya, Avinash, Khokhar, Ahmed, Laudermilch, Ethan, Dieterle, M Eugenia, Fels, J Maximilian, Haslwanter, Denise, Jangra, Rohit K, Barnhill, Jason, Almo, Steven C, Chandran, Kartik, Lai, Jonathan R, Kelly, Libusha, Daily, Johanna P, Vergnolle, Olivia
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The clinical outcome of SARS-CoV-2 infection varies widely between individuals. Machine learning models can support decision making in healthcare by assessing fatality risk in patients that do not yet show severe signs of COVID-19. Most predictive models rely on static demographic features and clinical values obtained upon hospitalization. However, time-dependent biomarkers associated with COVID-19 severity, such as antibody titers, can substantially contribute to the development of more accurate outcome models. Here we show that models trained on immune biomarkers, longitudinally monitored throughout hospitalization, predicted mortality and were more accurate than models based on demographic and clinical data upon hospital admission. Our best-performing predictive models were based on the temporal analysis of anti-SARS-CoV-2 Spike IgG titers, white blood cell (WBC), neutrophil and lymphocyte counts. These biomarkers, together with C-reactive protein and blood urea nitrogen levels, were found to correlate with severity of disease and mortality in a time-dependent manner. Shapley additive explanations of our model revealed the higher predictive value of day post-symptom onset (PSO) as hospitalization progresses and showed how immune biomarkers contribute to predict mortality. In sum, we demonstrate that the kinetics of immune biomarkers can inform clinical models to serve as a powerful monitoring tool for predicting fatality risk in hospitalized COVID-19 patients, underscoring the importance of contextualizing clinical parameters according to their time post-symptom onset.
ISSN:1553-7358
1553-734X
1553-7358
DOI:10.1371/journal.pcbi.1009778